HEART FAILURE FROM DIABETES DRUGS, ONGLYZA & KOMBIGLYZE XR- Federal Cases Centralized in the Eastern District of Kentucky

Diabetes Drug Lawsuits

On February 2, 2018, the Judicial Panel on Multidistrict Litigation (JPML) centralized federal lawsuits filed by individuals who have suffered heart failure after taking the diabetes drug saxagliptin (marketed as Onglyza and Kombiglyze XR) in multidistrict litigation (“MDL”) in the U.S. District Court, Eastern District of Kentucky before the Honorable Karen K. Caldwell. Saxagliptin is…

Read More

Heart Failure from Diabetes Drugs, Onglyza & Kombiglyze- 1/4/18 LITIGATION UPDATE

Diabetes Drug Lawsuits

The Judicial Panel on Multidistrict Litigation (JPML) announced that it will hear arguments on January 25, 2018 regarding whether to centralize federal lawsuits filed by individuals who have suffered heart failure after taking the diabetes drug saxagliptin (marketed as Onglyza and Kombiglyze XR). (To review the JPML’s Hearing Session Order click here.)  Saxagliptin is part…

Read More